{"id":"W3130416374","doi":"10.1016/j.breast.2021.02.009","title":"Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Meta-analysis; Breast cancer; Internal medicine; Oncology; Subgroup analysis; Adjuvant therapy; Population; Randomized controlled trial; MEDLINE; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003535956,0.0007820409,0.005560467,0.00008962409,0.0001661971,0.00004059506,0.0004213291,0.0001133072,0.0000855176],"category_scores_gemma":[0.00006474661,0.0003835436,0.001455049,0.0007776348,0.000325272,0.00001219224,0.0002745398,0.0002529563,0.000001913313],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005794195,"about_ca_system_score_gemma":0.0001404258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001837943,"about_ca_topic_score_gemma":0.0005142744,"domain_scores_codex":[0.9963191,0.001324477,0.0008279092,0.0008210134,0.0003709978,0.0003365469],"domain_scores_gemma":[0.9964359,0.0001939426,0.00162315,0.001069368,0.0005845969,0.00009297884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00009699307,0.0003706859,0.01209282,0.2193394,0.7262739,0.000009101415,0.0002101909,0.000003184469,3.168539e-7,0.000004122251,0.0001107713,0.04148849],"study_design_scores_gemma":[0.0004318318,0.0000970301,0.05008258,0.04845745,0.8997729,0.0001360004,0.00002086857,2.786901e-7,0.0000053011,0.000002031596,0.0004219475,0.000571724],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004985933,0.9902605,0.0000115947,0.00009222043,0.00002385932,0.002266458,0.006805932,0.000009267576,0.00003156211],"genre_scores_gemma":[0.006344754,0.9915749,0.00004694748,0.00006123931,0.00003577757,0.001404345,0.0003333236,0.00006360655,0.0001351021],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1734991,"threshold_uncertainty_score":0.9998617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01952090288958928,"score_gpt":0.2870374293321055,"score_spread":0.2675165264425162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}